Linatab M 2.5/1000 Tablet
৳ 150
- Combination of DPP-4 inhibitor and biguanide
- Dual mechanism for enhanced glycemic control
- Increases insulin secretion and decreases hepatic glucose production
- Suitable for patients not adequately controlled with monotherapy
- Low risk of hypoglycemia when used without insulin or sulfonylureas
- To be taken with meals to improve gastrointestinal tolerability (as prescribed)
Linatab M 2.5/1000 Tablet is a fixed-dose combination of Linagliptin and Metformin Hydrochloride, indicated for the management of type 2 diabetes mellitus. Linagliptin, a DPP-4 inhibitor, enhances incretin hormone activity, resulting in increased glucose-dependent insulin secretion and reduced glucagon levels. Metformin, a biguanide, decreases hepatic glucose production and improves peripheral insulin sensitivity.
This combination offers complementary mechanisms of action, leading to improved glycemic control compared to single-agent therapy. The higher metformin strength (1000 mg) is typically used in patients requiring more intensive glucose lowering.
For optimal tolerability, particularly to minimize gastrointestinal side effects associated with metformin, the tablet should be taken with meals. Dosage should be individualized based on clinical response and patient condition, under the supervision of a registered physician. Regular monitoring of blood glucose levels is recommended during treatment.
Unit Price: 15.00 Tk
Strip Price: 150.00 Tk
Reviews
There are no reviews yet.